[The preliminary results of using tramal in rheumatoid arthritis patients].
Patients suffering from active rheumatoid arthritis (RA) were examined for the analgesic effect of tramal. All the patients were administered basic therapy and nonsteroidal anti-inflammatory drugs. Tramal produced a beneficial effect in 79% of the patients. The stable analgesic effect ensued on days 3-5 since the onset of continuous treatment. Provided the drug was administered for a short period of time (not more than 14 days), addiction to tramal was not recorded. Only 11% of the patients demonstrated tramal-induced side effects (drowsiness, dizziness, skin itch), seen in cases where the daily dose exceeded 300 mg.
Makolkin
V I
VI
Bazhanov
N N
NN
Petukhova
N V
NV
Men'shikova
I V
IV
D000293:Adolescent; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors; D014147:Tramadol / Q000009:adverse effects / Q000627:therapeutic use*
D014147:Tramadol
Predvaritel'nye rezul'taty ispol'zovaniia tramala u bol'nykh revmatoidnym artritom.